Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

GREY:IVITF - Post Discussion

Invictus MD Strategies Corp > Great news....Invictus selling out of product.
View:
Post by billwhite on Sep 26, 2019 8:43am

Great news....Invictus selling out of product.

Checking the Cannibas store the past few days,  acreage pharms (Invictus)  is selling out of their newest strands of Cannabis.  The mixed blend and rewind sold out in the 3.5 g sizes and the western star and Mazar in the smaller quantities.  Great selection.  I wonder if they have surpassed their 2000kg of production?  Great buying opportunity, especially with a short squeeze..
https://albertacannabis.org/search?q=Acreage&f=in_stock%3Dtrue%7Cfalse
Comment by billwhite on Sep 26, 2019 3:54pm
These great buying opportunities at these deflated prices are going to cost you more going forward. If we do more than 4 million in revenues last quarter, quarter report next week, we should see a spike up..
Comment by gamos99 on Sep 26, 2019 5:57pm
Based on last quarter's #s, and our now increased capacity, $4M rev is possible: As a refresher, here are Q1 2019 earnings (reported June 28, 2019)(quarter ended April 30, 2019) revenue: $1.6M  // expenses: $4M // net income_loss: - $4.6M (previous Q was -$14.3M) // EPS: -$0.04 // Earnings reaction: 0 % (These earnings include just one quarter of OCS sales). // Cash on hand: $3 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities